SAMI Pharmaceuticals products and prices in Pakistan
Manufacturer Holds a DRAP Drug Manufacturing Licence (DML) for its products. Source: DRAP.
Follow price changes 🔒 Company report (Pharma Pro)Private pharmaceutical manufacturer · Karachi · Pakistan
Karachi-based pharmaceutical manufacturer and marketer of branded generic medicines across major therapeutic categories.
SAMI Pharmaceuticals products in Pakistan
SAMI Pharmaceuticals Pvt. Ltd has 188 medicine presentations registered in Pakistan under 67 brands, covering 63 generic medicines. Most of its products are in Anti-infectives, Cardiovascular and Endocrine & metabolic. Its brands with the most registered strengths and packs are RYBIO (Ribavirin), TELARB-Plus (Telmisartan + Amlodipine), EMPOLI (Empagliflozin) and NOVIDAT (Ciprofloxacin). 188 products have an official DRAP price on MedInfoBase. See all 67 brands A to Z
What is sourced, and how recent is it?
Regulatory-source portfolio data and company-supplied/corporate profile fields are tracked separately. Company claim/verification status is separate from source quality. An unclaimed company can still have a fully official-source-observed portfolio.
Company profile
- Legal / official name
- SAMI Pharmaceuticals (Pvt.) Ltd.
- Company type
- Private pharmaceutical manufacturer
- Address
- 34-C, Block-6, P.E.C.H.S., Karachi-75350, Pakistan · 75350
- Website
- samipharma.com ↗
- Phone
- +92 21 34527490-92
- samiho@samikhi.com
- Official contact
- Contact page ↗
- Corporate source details checked
- 16 Aug 2026
- Corporate profile completeness
- 100%
Company location
A sourced company location is recorded. Use the map link below for directions.
Portfolio at a glance
RegistrationA unique regulatory registration number. One registration may have more than one strength/form/pack presentation.
PresentationA distinct medicine presentation, such as a particular strength, dosage form and pack.
IndexedA canonical MedInfoBase presentation that passed MedInfoBase identity and publication controls.
Source observedAn additional presentation observed in an official DRAP source but not counted as an indexed MedInfoBase presentation.
Registry onlyAn exact registry-verified registration not otherwise represented by an indexed or source-observed presentation.
Registry verifiedAn exact registration match found in an official DRAP registry source. This is evidence status, not a commercial ranking.
How complete is this profile?
Downloadable company intelligence charts
Copy or download any chart as a presentation-ready PNG. Every exported chart keeps MedInfoBase attribution and the source company-profile URL.
Therapeutic Portfolio Mix
Shows where the company portfolio is concentrated across broad therapeutic areas.
Portfolio distribution, not sales or market-share data.
Dosage Form Portfolio
Shows how the company portfolio is distributed across tablets, capsules, injections, liquids and other forms.
Counts are product presentations, not production or sales volumes.
Equivalent Price Position
Shows whether safely comparable products are below, near or above the peer median unit price.
This is price-position intelligence, not sales, demand or market-share data.
Closest Portfolio Competitors
Highlights other manufacturers with the greatest generic overlap with this company portfolio.
Competitor ranking is based on shared generics in MedInfoBase, not commercial sales performance.
Therapeutic areas
High-level clinical areas represented by this company’s current MedInfoBase portfolio.
Drug classes
More specific classes derived from the canonical generic and preserved curated classifications.
Dosage forms
How MedInfoBase classifies the portfolio
MedInfoBase uses a two-level taxonomy. Therapeutic area is a broad portfolio category, while drug class is the more specific pharmacological or clinical class. Existing curated classifications are preserved. Blank records are assigned conservatively from the canonical generic name and, when available, ATC information. Multi-use medicines may be placed in a cross-therapeutic category rather than forced into a single indication.
Deepest brand families
Unit-price positioning vs equivalent products
See where SAMI Pharmaceuticals Pvt. Ltd. is priced against the market
176 of its products have like-for-like competitors. Pharma Pro shows how many are priced below, near or above the market median, the company's overall price position, and product-by-product examples.
How MedInfoBase calculates price position
Only current prices with safely interpretable pack quantities are used. A product is compared only with the same generic, same stated strength, same dosage form and a compatible unit basis such as tablet, capsule, mL or gram. These are database-derived price comparisons, not sales or market-share estimates.
Portfolio overlap
Companies sharing the largest number of generics with this portfolio. This measures product overlap, not commercial performance.
🔒 3 more overlapping companies, with shared-generic detail, in Pharma Pro. Unlock
Observed database signals
These dates describe records observed by MedInfoBase. They should not be interpreted as product launch dates or sales activity.
Medicine portfolio
This unified portfolio keeps three evidence lanes distinct: indexed MedInfoBase presentations, additional source-observed presentations, and registry-only registrations that are not otherwise represented. A registration number is not the same thing as a presentation, and source-observed rows are not counted as indexed. Source-only rows with a strength/form/pack contradiction remain visible as evidence but the conflicting field is held for normalization.
| Brand | Generic | Strength | Form | Pack | Registration | Source-listed price | Unit price | Price position |
|---|---|---|---|---|---|---|---|---|
| Minrova 15mg TabletRegistry verified | Mirogabalin Besylate eq. to Mirogabalin | — | — | — | 131028Official source ↗ | No indexed price | — | — |
| Minrova 2.5mg TabletRegistry verified | Mirogabalin Besylate eq. to Mirogabalin | — | — | — | 131027Official source ↗ | No indexed price | — | — |
| Minrova 5mg TabletRegistry verified | Mirogabalin Besylate eq. to Mirogabalin | — | — | — | 131026Official source ↗ | No indexed price | — | — |
| MOFEST | Moxifloxacin | 400 mg | Tablet | 5's | 050745 | PKR 994.60 | PKR 198.92/tablet | 🔒 Pharma Pro |
| Mofest 400mg InfusionRegistry verified | Moxifloxacin | — | — | — | 053227Official source ↗ | No indexed price | — | — |
| Neege 40mg InjectionRegistry verified | Pantoprazole Sodium | — | — | — | 057832Official source ↗ | No indexed price | — | — |
| Neege 40mg TabletRegistry verified | Pantoprazole Sodium | — | — | — | 039504Official source ↗ | No indexed price | — | — |
| Neo Sedil 5mg TabletRegistry verified | Levocetirizine Dihydrochloride | — | — | — | 061244Official source ↗ | No indexed price | — | — |
| Neo-Antial 5mg tabletRegistry verified | Desloratadine | — | — | — | 061440Official source ↗ | No indexed price | — | — |
| Neo-Sedil 2.5mg/5mg Oral SoulutionRegistry verified | Levocetirizine dihydrochloride | — | — | — | 076065Official source ↗ | No indexed price | — | — |
| NEOFIL | Filgrastim (rHuG-CSF) | 300 mcg | Injection | Vial | 079807 | PKR 6,719.55 | PKR 6,719.55/vial/unit | No comparator |
| NIVADOR | Ceftazidime | 250 mg | Injection | Vial | 037548 | PKR 167.86 | PKR 167.86/vial/unit | 🔒 Pharma Pro |
| NIVADOR | Ceftazidime | 500 mg | Injection | Vial | 037549 | PKR 255.31 | PKR 255.31/vial/unit | 🔒 Pharma Pro |
| NIVADOR | Ceftazidime | 1 g | Injection | Vial | 037550 | PKR 479.56 | PKR 479.56/vial/unit | 🔒 Pharma Pro |
| Nivador AV | Ceftazidime + Avibactam | 2 g + 0.5 g | Injection | 1's | 135108 | PKR 7,923.00 | PKR 7,923.00/vial/unit | 🔒 Pharma Pro |
| NOVIDAT | Ciprofloxacin | 250 mg | Tablet | 10's | 011836 | PKR 367.98 | PKR 36.80/tablet | 🔒 Pharma Pro |
| NOVIDAT | Ciprofloxacin | 500 mg | Tablet | 10's | 011837 | PKR 647.69 | PKR 64.77/tablet | 🔒 Pharma Pro |
| NOVIDAT | Ciprofloxacin | 200 mg/100 mL | IV infusion | 100 ml | 012066 | PKR 619.59 | PKR 6.20/mL | 🔒 Pharma Pro |
| NOVIDAT | Ciprofloxacin | 750 mg | Tablet | 10's | 026883 | PKR 433.72 | PKR 43.37/tablet | 🔒 Pharma Pro |
| NOVIDAT | Ciprofloxacin | 400 mg/100 mL | IV infusion | 100 ml | 042270 | PKR 340.80 | PKR 3.41/mL | 🔒 Pharma Pro |
| NOVIDAT | Ciprofloxacin | 250 mg/5 mL | Suspension | 60 ml | 047142 | PKR 330.47 | PKR 5.51/mL | 🔒 Pharma Pro |
| NOVIDAT | Ciprofloxacin | 125 mg/5 mL | Dry suspension | 60 ml | 067166 | PKR 222.36 | PKR 3.71/mL | 🔒 Pharma Pro |
| Novidat XR | Ciprofloxacin | 500 mg | Extended-release tablet | 10's | 076578 | PKR 537.00 | PKR 53.70/tablet | 🔒 Pharma Pro |
| Novidat XR | Ciprofloxacin | 1000 mg | Extended-release tablet | 10's | 076579 | PKR 753.84 | PKR 75.38/tablet | 🔒 Pharma Pro |
| OCVIR | Sofosbuvir | 400 mg | Tablet | 28's | 080175 | PKR 12,119.44 | PKR 432.84/tablet | 🔒 Pharma Pro |
| OCVIR-V | Sofosbuvir + Velpatasvir | 400 mg + 100 mg | Tablet | 28's | 089075 | PKR 19,947.37 | PKR 712.41/tablet | 🔒 Pharma Pro |
| OLMETHATE | Colistimethate sodium | 150 mg | Injection | 1's | 116087 | PKR 4,501.60 | PKR 4,501.60/vial/unit | 🔒 Pharma Pro |
| OLMETHATE | Colistimethate sodium | 1 MIU | Injection | 1's | 120046 | PKR 1,108.52 | PKR 1,108.52/vial/unit | 🔒 Pharma Pro |
| OLMETHATE | Colistimethate sodium | 2 MIU | Injection | 1's | 120047 | PKR 1,847.89 | PKR 1,847.89/vial/unit | 🔒 Pharma Pro |
| ONATO | Amlodipine | 10 mg | Tablet | 3x10's | 024499 | PKR 306.69 | PKR 10.22/tablet | 🔒 Pharma Pro |
| ONATO | Amlodipine | 10 mg | Tablet | 20's | 024499 | PKR 204.47 | PKR 10.22/tablet | 🔒 Pharma Pro |
| ONATO | Amlodipine | 5 mg | Tablet | 3x10's | 027777 | PKR 494.02 | PKR 16.47/tablet | 🔒 Pharma Pro |
| ONATO | Amlodipine | 5 mg | Tablet | 20's | 027777 | PKR 329.35 | PKR 16.47/tablet | 🔒 Pharma Pro |
| Onato-V 10/160mg TabletRegistry verified | Amlodipine besylate eq to amlodipine, Valsartan | — | — | — | 088214Official source ↗ | No indexed price | — | — |
| Onato-V 5/160mg TabletRegistry verified | Amlodipine besylate eq to amlodipine, Valsartan | — | — | — | 088213Official source ↗ | No indexed price | — | — |
| Onato-V 5/80mg TabletRegistry verified | Amlodipine besylate eq to amlodipine, Valsartan | — | — | — | 088212Official source ↗ | No indexed price | — | — |
| ONTIV | Ondansetron | 8 mg | Tablet | 10's | 114500 | PKR 1,800.70 | PKR 180.07/tablet | 🔒 Pharma Pro |
| ONTIV | Ondansetron | 4 mg/2 mL | Injection | 2mlx5's | 116249 | PKR 2,885.80 | PKR 288.58/mL | 🔒 Pharma Pro |
| ONTIV | Ondansetron | 4 mg/2 mL | Injection | 2ml | 116249 | PKR 577.76 | PKR 288.88/mL | 🔒 Pharma Pro |
| ONTIV | Ondansetron | 8 mg/4 mL | Injection | 4mlx5's | 116250 | PKR 5,156.30 | PKR 257.82/mL | 🔒 Pharma Pro |
| ONTIV | Ondansetron | 8 mg/4 mL | Injection | 4ml | 116250 | PKR 1,031.28 | PKR 257.82/mL | 🔒 Pharma Pro |
| Ontiv 4mg/5ml Oral SolutionRegistry verified | Ondansetron Hydrochloride | — | — | — | 130875Official source ↗ | No indexed price | — | — |
| Orglu InjectionRegistry verified | Phloroglucinol Hydrate, Trimethylphloroglucinol | — | — | — | 100100Official source ↗ | No indexed price | — | — |
| OSIRIS Quick | Zinc | 10 mg | Tablet | 30's | 074897 | PKR 183.74 | PKR 6.12/tablet | 🔒 Pharma Pro |
| OSIRIS Quick | Zinc | 20 mg | Tablet | 10's | 074898 | PKR 103.27 | PKR 10.33/tablet | 🔒 Pharma Pro |
| OXIDIL | Ceftriaxone | 500 mg | IV injection | Vial | 022421 | PKR 433.72 | PKR 433.72/vial/unit | 🔒 Pharma Pro |
| OXIDIL | Ceftriaxone | 1 g | IV injection | Vial | 022422 | PKR 846.78 | PKR 846.78/vial/unit | 🔒 Pharma Pro |
| OXIDIL | Ceftriaxone | 500 mg | IM injection | Vial | 022967 | PKR 433.72 | PKR 433.72/vial/unit | 🔒 Pharma Pro |
| OXIDIL | Ceftriaxone | 250 mg | IM injection | Vial | 023073 | PKR 237.51 | PKR 237.51/vial/unit | 🔒 Pharma Pro |
| OXIDIL | Ceftriaxone | 250 mg | IV injection | Vial | 023393 | PKR 237.51 | PKR 237.51/vial/unit | 🔒 Pharma Pro |
All 67 SAMI Pharmaceuticals brands in Pakistan
- ACTIM Bisoprolol fumarate · 10 mg tablet, 2.5 mg tablet, 5 mg tablet
- ANTIAL Loratadine · 10 mg tablet, 5 mg/5 mL solution
- Arcenate Artesunate · 120 mg injection, 30 mg injection, 60 mg injection
- ARCEVA Artemether + Lumefantrine, Artemether · 40 mg + 240 mg tablet, 80 mg + 480 mg tablet, 80 mg/mL injection
- ARCEVA 20 Artemether + Lumefantrine · 20 mg + 120 mg tablet
- ARILIO Tacrolimus · 0.5 mg capsule, 1 mg capsule, 5 mg capsule
- ARNEZA Anastrozole · 1 mg tablet
- AZITMA Azithromycin · 200 mg/5 mL suspension, 250 mg tablet, 500 mg tablet
- BELIC Entecavir · 0.05 mg/mL solution, 1 mg tablet
- BISLERI Iron polymaltose complex + Folic acid · 100 mg + 350 mcg capsule, 100 mg + 350 mcg tablet, 100 mg elemental iron + 350 mcg folic acid tablet
- BREEKY Misoprostol · 200 mcg tablet
- BRINO Tranexamic acid · 250 mg/5 mL injection, 500 mg/5 mL injection
- Caffcit Caffeine citrate · 20 mg/mL infusion
- CARICEF Cefixime · 100 mg/5 mL suspension, 200 mg tablet, 200 mg/5 mL suspension
- CERN-C Ascorbic acid · 500 mg tablet
- Cynfo Fosfomycin · 1 g infusion
- D-TRES Cholecalciferol · 5 mg injection, 5 mg/mL injection
- DEVAZO Daclatasvir · 30 mg tablet, 60 mg tablet
- ECASIL Linezolid · 100 mg/5 mL suspension, 200 mg/100 mL infusion, 400 mg tablet
- EFFIFLOX Levofloxacin · 250 mg tablet, 500 mg tablet
- EMPOLI Empagliflozin · 10 mg tablet, 25 mg tablet
- ENORIN Enoxaparin · 4000 IU injection, 6000 IU injection
- Fungone Fluconazole · 100 mg/50 mL infusion, 150 mg capsule, 50 mg capsule
- GLYMO-XR Metformin · 1000 mg tablet, 500 mg tablet, 750 mg tablet
- Grasil Amikacin · 100 mg injection, 25 mg/1 mL injection, 250 mg injection
- GRUDIZ Letrozole · 2.5 mg tablet
- IDZO Midazolam · 5 mg/5 mL injection
- KLINT Metronidazole · 200 mg/5 mL suspension, 400 mg tablet
- KLINT Injection1 Metronidazole · 5 mg injection
- Mdestiv Remdesivir · 100 mg infusion
- Mefloq Mefloquine · 250 mg tablet
- MOFEST Moxifloxacin · 400 mg tablet
- NEOFIL Filgrastim (rHuG-CSF) · 300 mcg injection
- NIVADOR Ceftazidime · 1 g injection, 250 mg injection, 500 mg injection
- Nivador AV Ceftazidime + Avibactam · 2 g + 0.5 g injection
- NOVIDAT Ciprofloxacin · 125 mg/5 mL suspension, 200 mg/100 mL infusion, 250 mg tablet
- Novidat XR Ciprofloxacin · 1000 mg tablet, 500 mg tablet
- OCVIR Sofosbuvir · 400 mg tablet
- OCVIR-V Sofosbuvir + Velpatasvir · 400 mg + 100 mg tablet
- OLMETHATE Colistimethate sodium · 1 MIU injection, 150 mg injection, 2 MIU injection
- ONATO Amlodipine · 10 mg tablet, 5 mg tablet
- ONTIV Ondansetron · 4 mg/2 mL injection, 8 mg tablet, 8 mg/4 mL injection
- OSIRIS Quick Zinc · 10 mg tablet, 20 mg tablet
- OXIDIL Ceftriaxone · 1 g injection, 2 g injection, 250 mg injection
- PENORIT Norethisterone acetate + Ethinyl estradiol · 10 mg + 0.02 mg tablet
- PLATRID Clopidogrel · 75 mg tablet
- PROVAS Paracetamol · 120 mg/5 mL suspension, 250 MG/5 mL suspension, 500 mg tablet
- Provas Fastiv Paracetamol · 500 mg tablet
- RITHMO Clarithromycin · 250 mg tablet, 250 MG/5 mL suspension, 500 mg tablet
- RITHMO 125mg Clarithromycin · 125 mg/5 mL drops, 125 mg/5 mL suspension
- RITVY Lopinavir + Ritonavir · 200 mg + 50 mg tablet
- ROLAC Itraconazole · 100 mg capsule
- ROPO Erythropoietin · 10000 IU injection, 2000 IU injection, 4000 IU injection
- RYBIO Ribavirin · 200 mg tablet, 400 mg tablet, 400 mg capsule
- SALTIV Oseltamivir · 75 mg capsule
- SAMCLOM Clomifene citrate · 50 mg tablet
- SAMOCHIN Chloroquine · 250 mg tablet
- SAMULIN R Regular human insulin · 100 IU/mL injection
- SAMULIN-NPH Human insulin (isophane/NPH) · 100 IU/mL injection
- TELARB-H Telmisartan + Hydrochlorothiazide · 40 mg + 12.5 mg tablet, 80 mg + 12.5 mg tablet
- TELARB-Plus Telmisartan + Amlodipine · 40 mg + 10 mg tablet, 40 mg + 5 mg tablet, 80 mg + 10 mg tablet
- TePH Omeprazole · 20 mg capsule, 40 mg capsule, 40 mg infusion
- TIMEQUIN Dihydroartemisinin + Piperaquine · 40 mg + 320 mg capsule
- TULAC Lactulose · 66.70 g/100 mL syrup
- UBROF Ibuprofen · 400 mg/100 mL infusion, 600 mg/100 mL infusion, 800 mg/8 mL injection
- VORY Voriconazole · 200 mg tablet, 200 mg/5 mL suspension, 50 mg tablet
- ZIVALO of Zoledronic acid · 5 mg/100 mL solution
SAMI Pharmaceuticals: common questions
How many products does SAMI Pharmaceuticals have in Pakistan?
SAMI Pharmaceuticals Pvt. Ltd has 188 registered medicine presentations in Pakistan, sold under 67 brands and covering 63 generic medicines.
What are the main brands of SAMI Pharmaceuticals?
By number of registered strengths and packs, its largest brands are RYBIO (Ribavirin), TELARB-Plus (Telmisartan + Amlodipine), EMPOLI (Empagliflozin), NOVIDAT (Ciprofloxacin) and ARILIO (Tacrolimus). This is not a sales ranking.
Which therapy areas does SAMI Pharmaceuticals cover?
The most products are in Anti-infectives (95), Cardiovascular (24), Endocrine & metabolic (16), Oncology & immunology (9) and Vitamins, minerals & nutrition (9).
Where can I see SAMI Pharmaceuticals medicine prices?
Open any brand in the list above for its official DRAP price, pack sizes, price history and other brands of the same medicine.
MedInfoBase company-intelligence methodology
This page is generated from MedInfoBase medicine, generic, company, price and official-source records. Unverified third-party discovery records are retained internally for coverage auditing and are not published as company registrations. Portfolio leaders are ranked by presentation depth, not sales. Price-position metrics are calculated from current official-source prices normalized to compatible units and compared only against like-for-like products with the same generic, stated strength and dosage form.
Not currently included: sales volume, revenue by brand, market share, prescription volume or best-selling rankings. MedInfoBase will display those only when supported by a defensible licensed, public or company-verified source.
Cite this record
Manufacturer recordRecords change over time. Please cite the access date so readers can locate the version you used.